S. J. Galli, Pathogenesis and management of anaphylaxis: current status and future challenges, J Allergy Clin Immunol, vol.115, issue.3, pp.571-574, 2005.

A. I. Neugut, A. T. Ghatak, and R. L. Miller, Anaphylaxis in the United States: an investigation into its epidemiology, Arch Intern Med, vol.161, issue.1, pp.15-21, 2001.

P. Portier and C. Richet, De l'action anaphylactique de certain venins, CR Soc Biol (Paris), vol.54, p.170, 1902.

D. Dombrowicz, V. Flamand, K. K. Brigman, B. H. Koller, and J. P. Kinet, Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene, Cell, vol.75, issue.5, pp.969-976, 1993.

I. Miyajima, D. Dombrowicz, T. R. Martin, J. V. Ravetch, J. P. Kinet et al., Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE-or IgG1-dependent passive anaphylaxis, J Clin Invest, vol.99, issue.5, pp.901-914, 1997.

Y. Makabe-kobayashi, The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis, J Allergy Clin Immunol, vol.110, issue.2, pp.298-303, 2002.

S. Kimura, A. Watanabe, M. Takeuchi, M. Nagata, and M. Harada, Suppressive effects of antihistaminic and/or anti-PAF agents on passive anaphylactic shock in mice sensitized with allogeneic monoclonal IgE and IgG1 antibodies and hyperimmune serum, Immunol Invest, vol.27, issue.6, pp.379-393, 1998.

M. Daëron, C. Bonnerot, S. Latour, and W. H. Fridman, Murine recombinant Fc gamma RIII, but not Fc gamma RII, trigger serotonin release in rat basophilic leukemia cells, J Immunol, vol.149, issue.4, pp.1365-1373, 1992.

W. L. Hazenbos, Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice, Immunity, vol.5, issue.2, pp.181-188, 1996.

Y. Tsujimura, Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis, Immunity, vol.28, issue.4, pp.581-589, 2008.

M. Million, J. Fioramonti, J. M. Zajac, and L. Bueno, Effects of neuropeptide FF on intestinal motility and temperature changes induced by endotoxin and platelet-activating factor, Eur J Pharmacol, vol.334, issue.1, pp.67-73, 1997.

H. C. Oettgen, T. R. Martin, A. Wynshaw-boris, C. Deng, J. M. Drazen et al., Active anaphylaxis in IgEdeficient mice, Nature, vol.370, issue.6488, pp.367-370, 1994.

I. H. Choi, Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice, J Exp Med, vol.188, issue.9, pp.1587-1592, 1998.

C. Ohnmacht, C. Schwartz, M. Panzer, I. Schiedewitz, R. Naumann et al., Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths, Immunity, vol.33, issue.3, pp.364-374, 2010.

S. Ishii, Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor, J Exp Med, vol.187, issue.11, pp.1779-1788, 1998.

K. Arias, Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions, J Allergy Clin Immunol, vol.124, issue.2, pp.307-314, 2009.

D. A. Mancardi, B. Iannascoli, S. Hoos, P. England, M. Daeron et al., FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE-induced lung inflammation, J Clin Invest, vol.118, issue.11, pp.3738-3750, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-00363913

F. Nimmerjahn, P. Bruhns, K. Horiuchi, and J. V. Ravetch, Fc gamma RIV: a novel FcR with distinct IgG subclass specificity, Immunity, vol.23, issue.1, pp.41-51, 2005.

N. Van-rooijen and A. Sanders, Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications, J Immunol Methods, vol.174, issue.1-2, pp.83-93, 1994.

G. Z. Lotner, J. M. Lynch, S. J. Betz, and P. M. Henson, Human neutrophil-derived platelet activating factor, J Immunol, vol.124, issue.2, pp.676-684, 1980.

E. Jouvin-marche, E. Ninio, G. Beaurain, M. Tence, P. Niaudet et al., Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Pafacether and acetyl-transferase activity in human leukocytes, J Immunol, vol.133, issue.2, pp.892-898, 1984.

G. Virella, Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes, Immunology, vol.50, issue.1, pp.43-51, 1983.

S. J. Klebanoff, Myeloperoxidase: friend and foe, J Leukoc Biol, vol.77, issue.5, pp.598-625, 2005.

S. Gross, Bioluminescence imaging of myeloperoxidase activity in vivo, Nat Med, vol.15, issue.4, pp.455-461, 2009.

M. Maccioni, Arthritogenic monoclonal antibodies from K/BxN mice, J Exp Med, vol.195, issue.8, pp.1071-1077, 2002.

D. A. Mancardi, The murine high-affinity IgG receptor Fc(gamma)RIV is sufficient for autoantibody-induced arthritis, J Immunol, vol.186, issue.4, pp.1899-1903, 2011.

A. Braun, STIM1 is essential for Fcgamma receptor activation and autoimmune inflammation, Blood, vol.113, issue.5, pp.1097-1104, 2009.

J. V. Bonventre, Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2, Nature, vol.390, issue.6660, pp.622-625, 1997.

N. Uozumi, Role of cytosolic phospholipase A2 in allergic response and parturition, Nature, vol.390, issue.6660, pp.618-622, 1997.

B. P. Kennedy, A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains, J Biol Chem, vol.270, issue.38, pp.22378-22385, 1995.

R. P. Kimberly, J. W. Ahlstrom, M. E. Click, and J. C. Edberg, The glycosyl phosphatidylinositol-linked Fc gamma RIIIPMN mediates transmembrane signaling events distinct from Fc gamma RII, J Exp Med, vol.171, issue.4, pp.1239-1255, 1990.

N. Meknache, F. Jönsson, J. Laurent, M. T. Guinnepain, and M. Daëron, Human Basophils Express the Glycosylphosphatidylinositol-Anchored Low-Affinity IgG Receptor Fc{gamma}RIIIB (CD16B), J Immunol, vol.182, issue.4, pp.2542-2550, 2009.

R. T. Strait, S. C. Morris, M. Yang, X. W. Qu, and F. D. Finkelman, Pathways of anaphylaxis in the mouse, J Allergy Clin Immunol, vol.109, issue.4, pp.658-668, 2002.

X. Xu, Neutrophil histamine contributes to inflammation in mycoplasma pneumonia, J Exp Med, vol.203, issue.13, pp.2907-2917, 2006.

G. Camussi, M. Aglietta, R. Coda, F. Bussolino, W. Piacibello et al., Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils, Immunology, vol.42, issue.2, pp.191-199, 1981.

T. C. Lee, B. Malone, S. I. Wasserman, V. Fitzgerald, and F. Snyder, Activities of enzymes that metabolize platelet-activating factor (1-Alkyl-2-acetyl-snglycero-3-phosphocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore, Biochem Biophys Res Commun, vol.105, issue.4, pp.1303-1308, 1982.

C. Ra, M. H. Jouvin, U. Blank, and J. P. Kinet, A macrophage Fc gamma receptor and the mast cell receptor for IgE share an identical subunit, Nature, vol.341, issue.6244, pp.752-754, 1989.

D. Dombrowicz, V. Flamand, I. Miyajima, J. V. Ravetch, S. J. Galli et al., Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIIIdependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains, J Clin Invest, vol.99, issue.5, pp.915-925, 1997.

P. Bruhns, Specificity and affinity of human Fc{gamma} receptors and their polymorphic variants for human IgG subclasses, Blood, vol.113, issue.16, pp.3716-3725, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-00363931

M. Daëron, Fc receptor biology, Annu Rev Immunol, vol.15, pp.203-234, 1997.

A. S. Gounni, B. Lamkhioued, L. Koussih, C. Ra, P. M. Renzi et al., Human neutrophils express the high-affinity receptor for immunoglobulin E (Fc epsilon RI): role in asthma, FASEB J, vol.15, issue.6, pp.940-949, 2001.

P. Vadas, Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis, N Engl J Med, vol.358, issue.1, pp.28-35, 2008.

R. T. Strait, S. C. Morris, and F. D. Finkelman, IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking, J Clin Invest, vol.116, issue.3, pp.833-841, 2006.

F. Alves-rosa, C. Stanganelli, J. Cabrera, N. Van-rooijen, M. S. Palermo et al., Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model, Blood, vol.96, issue.8, pp.2834-2840, 2000.

Y. Kita, T. Takahashi, N. Uozumi, and T. Shimizu, A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry, Anal Biochem, vol.342, issue.1, pp.134-143, 2005.